The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy

Purpose: This study aimed to investigate the accuracy and clinical significance of an artificial intelligence (AI)-based automated Alberta Stroke Program Early Computed Tomography (ASPECT) scoring software of head CT for the indication of intravenous recombinant tissue plasminogen activator (rt-PA)...

Full description

Bibliographic Details
Main Authors: Soichiro Shibata, Kenzo Sakurai, Keiji Tachikawa, Riyoko Ko, Sakae Hino, Takayuki Fukano, Kenji Isahaya, Takafumi Haraguchi, Junji Yamauchi, Kenichiro Tanabe, Misako Nagasaka, Yuta Hagiwara, Takahiro Shimizu, Hisanao Akiyama, Yasuyuki Kobayashi, Yasuhiro Hasegawa, Yoshihisa Yamano
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Neurology International
Subjects:
artificial intelligence
recombinant tissue plasminogen activator therapy
ASPECTS
acute cerebral infarction
Online Access:https://www.mdpi.com/2035-8377/14/4/77

Internet

https://www.mdpi.com/2035-8377/14/4/77

Similar Items